SLRX
Salarius Pharmaceuticals Inc. Common Stock
$0.707+-0.000 (-0.000%)
Real-time Price
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.707
High
$0.707
Low
$0.707
Volume
0.07M
Company Fundamentals
Trading Stats
Related News
GlobeNewswire
Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses
CAMBRIDGE, Mass. and HOUSTON, March 26, 2025 (GLOBE NEWSWIRE) -- Decoy Therapeutics Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide-conjugate
View more
GlobeNewswire
Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update
Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of novel peptide conjugate therapeutics for treating respiratory viruses and
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.